Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023-A00181-44 | Other Identifier | ID-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. The probability of stroke recurrence is high: about 25% the first year , and 30 to 40% in the 5 years following the stroke. Recurrent strokes are responsible for significant disability, institutionalization, major neurocognitive disorders, and death.
In order to reduce the risk of stroke recurrence, multiple secondary prevention strategies have demonstrated their effectiveness, such as the prescription of drugs (in particular statins and antithrombotics), the establishment of a balanced diet, the practice of an activity physical, or even tobacco addiction.
However, the effectiveness of these strategies is optimal if and only if patients adhere to them.
In addition, previous studies have focused on the brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
In elderly patients, other obstacles could have been identified by specific studies, such as cognitive, sensory, functional disorders or even isolation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients having had a stroke | elderly patients previously treated with an antithrombotic and admitted to hospital for an ischemic stroke |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Analysis of the verbatim from the transcription of the recorded interviews. | Other | recorded semi-structured interviews between the patients and the pharmacist |
|
| Measure | Description | Time Frame |
|---|---|---|
| Analysis of the verbatim from the transcription of the recorded interviews. | Describing the content of discussions, relating to antithrombotic treatment for secondary prevention, between elderly patients previously treated with antithrombotics and admitted to hospital for an ischemic stroke and a pharmacist | one year |
| Measure | Description | Time Frame |
|---|---|---|
| Analysis of verbatim statements from the transcription of recorded interviews on patients' representations and beliefs regarding antithrombotics | Exploring patients' representations and beliefs regarding antithrombotics before and after the onset of stroke or recurrence of stroke | 15 to 60 minutes per patient |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients aged 65 and over, hospitalized for an ischemic stroke or a recurrence of ischemic stroke, being already treated with an antithrombotic treatment hospitalized at the Charpennes hospital with a plan to return home
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Teddy Novais, PharmD, PhD | Contact | +33472432155 | teddy.novais@chu-lyon.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| institute of aging - Hôpital des Charpennes | Recruiting | Villeurbanne | 69100 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Analysis of verbatim statements from the transcription of recorded interviews on patients' medication adherence to antithrombotics |
Explore patients' medication adherence to antithrombotics before the onset of stroke or recurrence of stroke |
| 15 to 60 minutes per patient |
| Analysis of verbatim statements from the transcription of recorded interviews on the impact of the occurrence of stroke or recurrence of stroke on medication adherence | Explore the impact of stroke occurrence or stroke recurrence on patient medication adherence (including motivation, ambivalence, confidence in medication benefits) | 15 to 60 minutes per patient |
| Analysis of verbatim statements from the transcription of recorded interviews on the obstacles and levers to medication adherence | Identify the barriers and levers to drug adherence with antithrombotics | 15 to 60 minutes per patient |
| ID | Term |
|---|---|
| D020521 | Stroke |
| D055118 | Medication Adherence |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided